18 Although the primary end point did not reach statistical significance, trends favored genotype-guided escalation to prasugrel or ticagrelor in LOF carriers.
← all excerpts
A systematic review and meta-analysis of the impact of clopidogrel responsiveness on ischemic and bleeding complications after noncoronary endovascular procedures.
1
—
—